John P. Saharek insider trades

Open-market stock purchases and sales by John P. Saharek, CEO & President, ImprimisRx at Harrow, Inc, from SEC Form 4 filings since Feb 1, 2015.

Recent trades

No open-market trades in the last 12 months.

Companies traded

  • HROW Harrow, Inc: other filings, last Apr 7, 2025
  • IMMY Imprimis Pharmaceuticals, Inc: other filings, last Feb 1, 2018

Get free alerts when John P. Saharek files a new trade →